BKYI Quote, Financials, Valuation and Earnings

Iveda Solutions has a net margin of -34.45% compared to BIO-key International's net margin of -23.14%. BIO-key International's return on equity of -662.7% beat Iveda Solutions's return on equity of -60.54%.

BIO-key International has a consensus price target of $3.00, signalling upside risk potential of 175.23%. On the other hand Iveda Solutions has an analysts' consensus of -- which suggests that it could grow by 186.74%. Given that Iveda Solutions has higher upside potential than BIO-key International, analysts believe Iveda Solutions is more attractive than BIO-key International.

BIO-key International has a beta of -0.101, which suggesting that the stock is 110.071% less volatile than S&P 500. In comparison Iveda Solutions has a beta of 0.882, suggesting its less volatile than the S&P 500 by 11.824%.

BIO-key International has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Iveda Solutions offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. BIO-key International pays -- of its earnings as a dividend. Iveda Solutions pays out -- of its earnings as a dividend.

BIO-key International quarterly revenues are $2.1M, which are smaller than Iveda Solutions quarterly revenues of $2.4M. BIO-key International's net income of -$739K is lower than Iveda Solutions's net income of -$555K. Notably, BIO-key International's price-to-earnings ratio is -- while Iveda Solutions's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BIO-key International is 0.21x versus 1.07x for Iveda Solutions. Usually stocks with elevated PS ratios are considered overvalued.

NAPCO Security Technologies has a net margin of -34.45% compared to BIO-key International's net margin of 24.38%. BIO-key International's return on equity of -662.7% beat NAPCO Security Technologies's return on equity of 28.2%.

BIO-key International has a consensus price target of $3.00, signalling upside risk potential of 175.23%. On the other hand NAPCO Security Technologies has an analysts' consensus of $30.40 which suggests that it could grow by 25.26%. Given that BIO-key International has higher upside potential than NAPCO Security Technologies, analysts believe BIO-key International is more attractive than NAPCO Security Technologies.

BIO-key International has a beta of -0.101, which suggesting that the stock is 110.071% less volatile than S&P 500. In comparison NAPCO Security Technologies has a beta of 1.589, suggesting its more volatile than the S&P 500 by 58.861%.

BIO-key International has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NAPCO Security Technologies offers a yield of 1.96% to investors and pays a quarterly dividend of $0.13 per share. BIO-key International pays -- of its earnings as a dividend. NAPCO Security Technologies pays out 26.61% of its earnings as a dividend. NAPCO Security Technologies's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

BIO-key International quarterly revenues are $2.1M, which are smaller than NAPCO Security Technologies quarterly revenues of $42.9M. BIO-key International's net income of -$739K is lower than NAPCO Security Technologies's net income of $10.5M. Notably, BIO-key International's price-to-earnings ratio is -- while NAPCO Security Technologies's PE ratio is 18.67x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BIO-key International is 0.21x versus 4.82x for NAPCO Security Technologies. Usually stocks with elevated PS ratios are considered overvalued.

Universal Security Instruments has a net margin of -34.45% compared to BIO-key International's net margin of -16.92%. BIO-key International's return on equity of -662.7% beat Universal Security Instruments's return on equity of -26.44%.

BIO-key International has a consensus price target of $3.00, signalling upside risk potential of 175.23%. On the other hand Universal Security Instruments has an analysts' consensus of -- which suggests that it could fall by --. Given that BIO-key International has higher upside potential than Universal Security Instruments, analysts believe BIO-key International is more attractive than Universal Security Instruments.

BIO-key International has a beta of -0.101, which suggesting that the stock is 110.071% less volatile than S&P 500. In comparison Universal Security Instruments has a beta of 0.661, suggesting its less volatile than the S&P 500 by 33.867%.

BIO-key International has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Universal Security Instruments offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. BIO-key International pays -- of its earnings as a dividend. Universal Security Instruments pays out -- of its earnings as a dividend.

BIO-key International quarterly revenues are $2.1M, which are smaller than Universal Security Instruments quarterly revenues of $5.5M. BIO-key International's net income of -$739K is higher than Universal Security Instruments's net income of -$936.6K. Notably, BIO-key International's price-to-earnings ratio is -- while Universal Security Instruments's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BIO-key International is 0.21x versus 0.19x for Universal Security Instruments. Usually stocks with elevated PS ratios are considered overvalued.

VerifyMe has a net margin of -34.45% compared to BIO-key International's net margin of -6.54%. BIO-key International's return on equity of -662.7% beat VerifyMe's return on equity of -33.15%.

BIO-key International has a consensus price target of $3.00, signalling upside risk potential of 175.23%. On the other hand VerifyMe has an analysts' consensus of $1.63 which suggests that it could grow by 103.43%. Given that BIO-key International has higher upside potential than VerifyMe, analysts believe BIO-key International is more attractive than VerifyMe.

BIO-key International has a beta of -0.101, which suggesting that the stock is 110.071% less volatile than S&P 500. In comparison VerifyMe has a beta of 0.507, suggesting its less volatile than the S&P 500 by 49.335%.

BIO-key International has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VerifyMe offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. BIO-key International pays -- of its earnings as a dividend. VerifyMe pays out -- of its earnings as a dividend.

BIO-key International quarterly revenues are $2.1M, which are smaller than VerifyMe quarterly revenues of $7.7M. BIO-key International's net income of -$739K is lower than VerifyMe's net income of -$501K. Notably, BIO-key International's price-to-earnings ratio is -- while VerifyMe's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for BIO-key International is 0.21x versus 0.34x for VerifyMe. Usually stocks with elevated PS ratios are considered overvalued.